Chadwick Jeremy G sold KYMR

April 1, 2026 · Form 4 insider transaction

Chadwick Jeremy G sold 1,100 shares of Kymera Therapeutics, Inc. at $86.05 per share, a transaction worth $94.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
1,100
Price
$86.05
Total value
$94.7K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 1, 2026
Shares owned after61,202
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.

View the original Form 4 on SEC EDGAR